4.8 Review

Amyotrophic lateral sclerosis

Journal

LANCET
Volume 390, Issue 10107, Pages 2084-2098

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(17)31287-4

Keywords

-

Funding

  1. European Community's Health Seventh Framework Programme (FP7)
  2. ZonMW
  3. JPND: Medical Research Council and Economic and Social Research Council, UK
  4. Health Research Board, Research Motor Neurone, Science Foundation, Ireland
  5. ZonMw, Netherlands
  6. Ministry of Education, University and Research, Italy
  7. L'Agence nationale pour la recherche, ALSA, France
  8. Italian Ministry of Health (Ricerca Sanitaria Finalizzata) [RF-2010-2309849]
  9. EU Joint Programme-Neurodegenerative Disease Research (Italian Ministry of Education and University)
  10. Fondazione Vialli e Mauro per la SLA Onlus
  11. Associazione Piemontese per l'Assistenza ally SEA (APASLA), Torino, Italy
  12. National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at the South London and Maudsley NIHS Foundation Trust and King's College London
  13. Ministry of Health, Italy
  14. SOPHIA Project
  15. Strength Project
  16. ALS-Care Project
  17. Economic and Social Research Council [ES/L008238/1] Funding Source: researchfish
  18. Medical Research Council [G0600974, MR/L501529/1] Funding Source: researchfish
  19. Motor Neurone Disease Association [AlChalabi-Talbot/Apr14/926-794] Funding Source: researchfish
  20. ESRC [ES/L008238/1] Funding Source: UKRI
  21. MRC [G0600974] Funding Source: UKRI

Ask authors/readers for more resources

Amyotrophic lateral sclerosis is characterised by the progressive loss of motor neurons in the brain and spinal cord. This neurodegenerative syndrome shares pathobiological features with frontotemporal dementia and, indeed, many patients show features of both diseases. Many different genes and pathophysiological processes contribute to the disease, and it will be necessary to understand this heterogeneity to find effective treatments. In this Seminar, we discuss clinical and diagnostic approaches as well as scientific advances in the research fields of genetics, disease modelling, biomarkers, and therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available